|
MAP3K3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.922200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.345900E-02 |
| Normal-vs-Stage2 |
3.723500E-03 |
| Normal-vs-Stage3 |
1.974200E-01 |
| Normal-vs-Stage4 |
8.393900E-02 |
| Stage1-vs-Stage2 |
6.008400E-02 |
| Stage1-vs-Stage3 |
7.474000E-01 |
| Stage1-vs-Stage4 |
7.785200E-01 |
| Stage2-vs-Stage3 |
6.893500E-02 |
| Stage2-vs-Stage4 |
1.900620E-01 |
| Stage3-vs-Stage4 |
6.415000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.058640E-01 |
| Normal-vs-AfricanAmerican |
7.966200E-01 |
| Normal-vs-Asian |
2.850600E-01 |
| Caucasian-vs-AfricanAmerican |
3.908200E-01 |
| Caucasian-vs-Asian |
8.062800E-01 |
| AfricanAmerican-vs-Asian |
5.675400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.256100E-02 |
| Normal-vs-Female |
7.109900E-02 |
| Male-vs-Female |
6.877800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.587200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.519900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.663100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.046020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.491000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.719900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.582600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.773190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.217200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.833600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.798200E-01 |
| Classical-VS-Follicular |
3.28479465849796E-11 |
| Classical-VS-Other |
2.926000E-01 |
| Classical-VS-Normal |
5.913200E-01 |
| Tall-VS-Follicular |
1.275070E-03 |
| Tall-VS-Other |
4.567200E-01 |
| Tall-VS-Normal |
2.927600E-01 |
| Follicular-VS-Other |
2.663400E-01 |
| Follicular-VS-Normal |
5.25120000038903E-07 |
| Other-VS-Normal |
1.900790E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.364300E-03 |
| Normal-vs-N1 |
4.063600E-02 |
| N0-vs-N1 |
8.536200E-01 |
|
|
